About this article Cite this article Yang, Y., Shao, Y., Tian, J
As a result, healthcare providers are increasingly considering tirzepatide as part of a comprehensive treatment plan for patients with obesity and type 2 diabetes
Observation periods included the in-trial period (that is, while in the trial, regardless of treatment discontinuation or rescue intervention) and the on-treatment period (with trial product)
Published studies on Akkermansia muciniphila, B420, and short-chain fatty acids reflect ingredient-level findings under specific research conditions
Tirzepatide was originally developed for the treatment of type 2 diabetes, but it has also proven effective in helping patients achieve significant weight loss